Mainz Biomed Signs MOU with OncoVanguard8 to Launch ColoAlert in South America
I'm PortAI, I can summarize articles.
Mainz Biomed NV has signed an MOU with OncoVanguard8 to launch its colorectal cancer screening test, ColoAlert, in South America, starting with Peru. The agreement covers commercial, legal, and regulatory terms, aiming to finalize a distribution deal soon. This AI-generated news is for informational purposes only and not financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments